Fig. 3: Forest plot of odds ratio or hazard ratios for ORR, PFS and OS in the subgroup analysis. | British Journal of Cancer

Fig. 3: Forest plot of odds ratio or hazard ratios for ORR, PFS and OS in the subgroup analysis.

From: Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis

Fig. 3

Forest plots showing ORR (a1), PFS (b1) and OS (c1) hazard ratio analyses in the first-line treated group, ORR (a2), PFS (b2) and OS (c2) hazard ratio analyses in the previously treated group, ORR (a3), PFS (b3) and OS (c3) hazard ratio analyses in the PD-1 inhibitor group, ORR (a4), PFS (b4) and OS (c4) hazard ratio analyses in the PD-L1 inhibitor group, PFS (b5) and OS (c5) hazard ratio analyses in the non-squamous group and PFS (b6) and OS (c6) hazard ratio analyses in the squamous group. ICI immune checkpoint inhibitors, chemo-ICI ICI-combined chemotherapy.

Back to article page